معرفی
Dr. Nazila Kamaly is an Associate Professor in the Department of Chemistry at Imperial College London, Faculty of Natural Sciences. She joined Imperial as faculty in 2019, following roles at Harvard Medical School, MIT, and the Technical University of Denmark. Her research focuses on developing targeted polymeric nanoparticles and biomaterials for stimuli-responsive drug delivery, leveraging bioinspired synthesis and biomicrofluidic models.
Education: PhD and MSci in Medicinal Chemistry from Imperial College London and University College London, respectively. Additional training includes postdoctoral work at Imperial, Harvard, and MIT.
Research interests include nanomedicine, drug delivery systems, and inflammation resolution. Her group develops nanoparticles for cancer, cardiovascular diseases, and inflammatory conditions, emphasizing spatiotemporal control via disease-marker responsiveness.
Key affiliations include the Institute of Chemical Biology, fabriCELL, and the Vascular Science Network. Notable achievements include a Lundbeck Fellowship (2019) for nanomedicine research in heart disease.
Publications span nanogel engineering, targeted therapies, and organ-on-chip platforms. Her work bridges polymer chemistry, biomedical engineering, and clinical translation, with applications in diagnostics and therapeutics.
